Target intelligence / Profile preview

Magnesium-dependent enzymes and ion channels

Molecular classification
Enzyme, Ion channel, Transporter, Receptor
01

Overview

Magnesium-dependent enzymes and ion channels constitute a broad category of proteins that utilize divalent magnesium (Mg2+) for catalytic activity, structural stability, or as a signaling mediator. Magnesium is a critical cofactor for over 300 enzymatic reactions, particularly those involving ATP, where it stabilizes phosphate groups to facilitate hydrolysis and energy transfer (NIH Office of Dietary Supplements, 2022). This group includes essential proteins such as DNA polymerases, kinases, and various ATPases, as well as specialized ion channels like TRPM6 and TRPM7 that regulate systemic magnesium levels (UniProt, 2023). Clinically, these proteins are vital for maintaining cardiovascular health, glucose metabolism, and neuronal excitability (StatPearls, 2023). Dysregulation of magnesium-dependent processes is associated with conditions such as hypomagnesemia, cardiac arrhythmias, and metabolic syndrome. Therapeutic strategies often focus on magnesium replacement therapy or the modulation of specific magnesium-permeable channels to restore physiological balance. Furthermore, magnesium acts as a natural calcium antagonist in many ion channels, influencing muscle contraction and neurotransmitter release (PubMed, 2021).

Other names
Magnesium-binding proteinsMg2+-dependent enzymesMagnesiotropic proteinsMagnesium transporters
02

Mechanism of action

Magnesium acts as a necessary enzymatic cofactor by stabilizing polyphosphate structures like ATP to facilitate phosphoryl transfer, serves as a charge carrier through specialized ion channels (e.g., TRPM6/7), and functions as a voltage-dependent blocker in receptors such as the NMDA receptor.

03

Biological functions

ATP metabolismDNA synthesisSignal transductionElectrolyte homeostasisMuscle contractionNerve conductionProtein synthesis
04

Disease associations

HypomagnesemiaCardiovascular diseaseType 2 diabetesNeurological disordersOsteoporosisHypertension
05

Safety considerations

HypermagnesemiaRenal impairment-induced toxicityNeuromuscular blockade at supratherapeutic levelsGastrointestinal distress (diarrhea)Drug-drug interactions via chelation
06

Interacting drugs

Magnesium sulfate

6 more in the full profile.

07

Biomarkers

Serum magnesium concentrationUrinary magnesium excretionFractional excretion of magnesiumIntracellular ionized magnesium

Beyond the preview

Go deeper on Magnesium-dependent enzymes and ion channels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium-dependent enzymes and ion channels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call